Skip to content

ICU Medical ICUI Derivative Liability

Derivative Liability at other companies

Edwards Lifesciences logo
Edwards LifesciencesEW
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.39B-6.3%

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:DerivativeLiabilities.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's derivative liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's derivative liability?
ICU Medical (ICUI) reported derivative liability of $6.54M in Q1 2026.
How has ICU Medical's derivative liability changed year-over-year?
ICU Medical's derivative liability increased by 50.7% year-over-year, from $4.34M to $6.54M.
What is the long-term trend for ICU Medical's derivative liability?
Over 4 years (2021 to 2025), ICU Medical's derivative liability has grown at a 37.2% compound annual growth rate (CAGR), from $1.48M to $5.25M.